Table 1. HumanMAP® v.1.6 analysis by Myriad RBM, Austin TX, USA.
| ANTIGEN | N* | ANTIGEN | N |
|---|---|---|---|
| Alpha-2-macroglobulin | 85 | Interleukin-4 | 36 |
| Alpha-1-Antitrypsin | 85 | Interleukin-5 | 67 |
| Adiponectin | 85 | Interleukin-6 | 55 |
| Alpha-Fetoprotein | 85 | Interleukin-7 | 56 |
| Apolipoprotein(a) | 84 | Interleukin-8 | 84 |
| Apolipoprotein A-I | 85 | Interleukin-10 | 79 |
| Apolipoprotein C-III | 85 | Interleukin-12p40 | 48 |
| Apolipoprotein H | 85 | Interleukin-12p70 | 14 |
| Beta-2-Microglobulin | 85 | Interleukin-13 | 71 |
| Brain-Derived Neurotrophic Factor | 85 | Interleukin-15 | 60 |
| Complement C3 | 85 | Interleukin-16 | 85 |
| Cancer Antigen 125 | 66 | Interleukin-18 | 85 |
| Cancer Antigen 19–9 | 81 | Insulin | 84 |
| Calcitonin | 82 | Leptin | 85 |
| CD 40 antigen | 85 | Lymphotactin | 2 |
| CD40 Ligand | 85 | Monocyte Chemotactic Protein 1 | 85 |
| Carcinoembryonic Antigen | 85 | Macrophage-Derived Chemokine | 85 |
| Creatine Kinase-MB | 84 | MIP-1 alpha | 85 |
| C-Reactive Protein | 84 | MIP-1 beta | 85 |
| Epidermal Growth Factor | 41 | Matrix Metalloproteinase-2 | 85 |
| ENA-78 | 85 | Matrix Metalloproteinase-3 | 27 |
| EN-RAGE | 60 | Matrix Metalloproteinase-9 | 85 |
| Eotaxin-1 | 73 | Myeloperoxidase | 78 |
| Erythropoietin | 34 | Myoglobin | 85 |
| Endothelin-1 | 43 | Plasminogen Activator Inhibitor 1 | 85 |
| Fatty Acid-Binding Protein 3 | 79 | Prostatic Acid Phosphatase | 85 |
| Factor VII | 85 | PAPPA | 72 |
| Fibroblast Growth Factor Basic | 16 | Prostate-Specific Antigen, Free | 85 |
| Fibrinogen | 85 | RANTES | 85 |
| Ferritin | 85 | Serum Amyloid P-Component | 85 |
| GCSF | 73 | Stem Cell Factor | 85 |
| Growth Hormone | 69 | SGOT | 84 |
| GM-CSF | 23 | Sex Hormone-Binding Globulin | 85 |
| Haptoglobin | 84 | Thyroxine-Binding Globulin | 85 |
| Intercellular Adhesion Molecule 1 | 85 | Tissue Factor | 29 |
| Interferon gamma | 29 | Tissue Inhibitor of Metalloproteinases 1 | 85 |
| Immunoglobulin A | 84 | Tumor Necrosis Factor alpha | 77 |
| Immunoglobulin E | 83 | Tumor Necrosis Factor beta | 27 |
| Immunoglobulin M | 85 | Tumor Necrosis Factor Receptor 2 | 85 |
| Interleukin-1 alpha | 52 | Thrombopoietin | 80 |
| Interleukin-1 beta | 24 | Thyroid-Stimulating Hormone | 84 |
| Interleukin-1 receptor antagonist | 77 | Vascular Cell Adhesion Molecule-1 | 85 |
| Interleukin-2 | 6 | VEGF | 85 |
| Interleukin-3 | 80 | vonWillebrand Factor | 85 |
* number of subjects which yielded protein concentrations above the lower limit of detection